254 related articles for article (PubMed ID: 15533909)
1. BRCA1 and BRCA2 mutations in a study of African American breast cancer patients.
Pal T; Permuth-Wey J; Holtje T; Sutphen R
Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1794-9. PubMed ID: 15533909
[TBL] [Abstract][Full Text] [Related]
2. Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry.
Nanda R; Schumm LP; Cummings S; Fackenthal JD; Sveen L; Ademuyiwa F; Cobleigh M; Esserman L; Lindor NM; Neuhausen SL; Olopade OI
JAMA; 2005 Oct; 294(15):1925-33. PubMed ID: 16234499
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer genetics in African Americans.
Olopade OI; Fackenthal JD; Dunston G; Tainsky MA; Collins F; Whitfield-Broome C
Cancer; 2003 Jan; 97(1 Suppl):236-45. PubMed ID: 12491487
[TBL] [Abstract][Full Text] [Related]
4. Next Generation Sequencing Reveals High Prevalence of BRCA1 and BRCA2 Variants of Unknown Significance in Early-Onset Breast Cancer in African American Women.
Ricks-Santi L; McDonald JT; Gold B; Dean M; Thompson N; Abbas M; Wilson B; Kanaan Y; Naab TJ; Dunston G
Ethn Dis; 2017; 27(2):169-178. PubMed ID: 28439188
[TBL] [Abstract][Full Text] [Related]
5. Large regional differences in the frequency of distinct BRCA1/BRCA2 mutations in 517 Dutch breast and/or ovarian cancer families.
Verhoog LC; van den Ouweland AM; Berns E; van Veghel-Plandsoen MM; van Staveren IL; Wagner A; Bartels CC; Tilanus-Linthorst MM; Devilee P; Seynaeve C; Halley DJ; Niermeijer MF; Klijn JG; Meijers-Heijboer H
Eur J Cancer; 2001 Nov; 37(16):2082-90. PubMed ID: 11597388
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of BRCA1 and BRCA2 mutations among clinic-based African American families with breast cancer.
Gao Q; Tomlinson G; Das S; Cummings S; Sveen L; Fackenthal J; Schumm P; Olopade OI
Hum Genet; 2000 Aug; 107(2):186-91. PubMed ID: 11030417
[TBL] [Abstract][Full Text] [Related]
7. Racial differences in the incidence of BRCA1 and BRCA2 mutations in a cohort of early onset breast cancer patients: African American compared to white women.
Haffty BG; Silber A; Matloff E; Chung J; Lannin D
J Med Genet; 2006 Feb; 43(2):133-7. PubMed ID: 15983021
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population.
Meindl A;
Int J Cancer; 2002 Feb; 97(4):472-80. PubMed ID: 11802209
[TBL] [Abstract][Full Text] [Related]
9. High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients.
Fackenthal JD; Zhang J; Zhang B; Zheng Y; Hagos F; Burrill DR; Niu Q; Huo D; Sveen WE; Ogundiran T; Adebamowo C; Odetunde A; Falusi AG; Olopade OI
Int J Cancer; 2012 Sep; 131(5):1114-23. PubMed ID: 22034289
[TBL] [Abstract][Full Text] [Related]
10. BRCA1/2 in high-risk African American women with breast cancer: providing genetic testing through various recruitment strategies.
Pal T; Vadaparampil S; Betts J; Miree C; Li S; Narod SA
Genet Test; 2008 Sep; 12(3):401-7. PubMed ID: 18752448
[TBL] [Abstract][Full Text] [Related]
11. BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer.
Hall MJ; Reid JE; Burbidge LA; Pruss D; Deffenbaugh AM; Frye C; Wenstrup RJ; Ward BE; Scholl TA; Noll WW
Cancer; 2009 May; 115(10):2222-33. PubMed ID: 19241424
[TBL] [Abstract][Full Text] [Related]
12. Recurrent BRCA1 and BRCA2 mutations in breast cancer patients of African ancestry.
Zhang J; Fackenthal JD; Zheng Y; Huo D; Hou N; Niu Q; Zvosec C; Ogundiran TO; Hennis AJ; Leske MC; Nemesure B; Wu SY; Olopade OI
Breast Cancer Res Treat; 2012 Jul; 134(2):889-94. PubMed ID: 22739995
[TBL] [Abstract][Full Text] [Related]
13. [The limited spectrum of pathogenic BRCA1 and BRCA2 mutations in the French Canadian breast and breast-ovarian cancer families, a founder population of Quebec, Canada].
Tonin PN
Bull Cancer; 2006 Sep; 93(9):841-6. PubMed ID: 16980226
[TBL] [Abstract][Full Text] [Related]
14. The spectrum of BRCA1 and BRCA2 mutations in breast cancer patients in the Bahamas.
Akbari MR; Donenberg T; Lunn J; Curling D; Turnquest T; Krill-Jackson E; Zhang S; Narod SA; Hurley J
Clin Genet; 2014 Jan; 85(1):64-7. PubMed ID: 23458327
[TBL] [Abstract][Full Text] [Related]
15. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL
Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian Breast Cancer Study Group.
Anglian Breast Cancer Study Group
Br J Cancer; 2000 Nov; 83(10):1301-8. PubMed ID: 11044354
[TBL] [Abstract][Full Text] [Related]
17. BRCA1 and BRCA2 mutation frequency in women evaluated in a breast cancer risk evaluation clinic.
Shih HA; Couch FJ; Nathanson KL; Blackwood MA; Rebbeck TR; Armstrong KA; Calzone K; Stopfer J; Seal S; Stratton MR; Weber BL
J Clin Oncol; 2002 Feb; 20(4):994-9. PubMed ID: 11844822
[TBL] [Abstract][Full Text] [Related]
18. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.
Hedau S; Jain N; Husain SA; Mandal AK; Ray G; Shahid M; Kant R; Gupta V; Shukla NK; Deo SS; Das BC
Breast Cancer Res Treat; 2004 Nov; 88(2):177-86. PubMed ID: 15564800
[TBL] [Abstract][Full Text] [Related]
19. BRCA2 in American families with four or more cases of breast or ovarian cancer: recurrent and novel mutations, variable expression, penetrance, and the possibility of families whose cancer is not attributable to BRCA1 or BRCA2.
Schubert EL; Lee MK; Mefford HC; Argonza RH; Morrow JE; Hull J; Dann JL; King MC
Am J Hum Genet; 1997 May; 60(5):1031-40. PubMed ID: 9150150
[TBL] [Abstract][Full Text] [Related]
20. High proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague area.
Pohlreich P; Zikan M; Stribrna J; Kleibl Z; Janatova M; Kotlas J; Zidovska J; Novotny J; Petruzelka L; Szabo C; Matous B
Breast Cancer Res; 2005; 7(5):R728-36. PubMed ID: 16168118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
